Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Schizophrenia

  Free Subscription


11.02.2019

1 Acta Psychiatr Scand
1 Am J Med Genet B Neuropsychiatr Genet
1 Br J Psychiatry
1 Int J Geriatr Psychiatry
2 J Nerv Ment Dis
1 Mol Psychiatry
1 Neuropsychopharmacology
1 Pharmacopsychiatry
1 PLoS One
6 Psychiatry Res
2 Psychol Med
15 Schizophr Res


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Psychiatr Scand

  1. DANEAULT JG, Maraj A, Lepage M, Malla A, et al
    Medication adherence in first episode psychosis: The role of pre-onset sub-threshold symptoms.
    Acta Psychiatr Scand. 2019 Feb 3. doi: 10.1111/acps.13011.
    PubMed     Text format     Abstract available


    Am J Med Genet B Neuropsychiatr Genet

  2. POSTOLACHE TT, Del Bosque-Plata L, Jabbour S, Vergare M, et al
    Co-shared genetics and possible risk gene pathway partially explain the comorbidity of schizophrenia, major depressive disorder, type 2 diabetes, and metabolic syndrome.
    Am J Med Genet B Neuropsychiatr Genet. 2019 Feb 6. doi: 10.1002/ajmg.b.32712.
    PubMed     Text format     Abstract available


    Br J Psychiatry

  3. XIANG B, Wang Q, Lei W, Li M, et al
    Genes in immune pathways associated with abnormal white matter integrity in first-episode and treatment-naive patients with schizophrenia.
    Br J Psychiatry. 2019 Feb 6:1-7. doi: 10.1192/bjp.2018.
    PubMed     Text format     Abstract available


    Int J Geriatr Psychiatry

  4. HABIGER TF, Achterberg WP, Flo E, Husebo BS, et al
    Psychosis symptoms in nursing home residents with and without dementia - cross-sectional analyses from the COSMOS study.
    Int J Geriatr Psychiatry. 2019 Jan 31. doi: 10.1002/gps.5067.
    PubMed     Text format     Abstract available


    J Nerv Ment Dis

  5. TONNA M, Ottoni R, Pellegrini C, Bettini E, et al
    The "Obsessive Paradox": The Complex Relationship Between Cognitive and Obsessive Dimensions in Schizophrenia.
    J Nerv Ment Dis. 2019 Jan 31. doi: 10.1097/NMD.0000000000000932.
    PubMed     Text format     Abstract available

  6. LECOMTE T, Theroux L, Paquin K, Potvin S, et al
    Can Social Anxiety Impact Facial Emotion Recognition in Schizophrenia?
    J Nerv Ment Dis. 2019 Jan 31. doi: 10.1097/NMD.0000000000000934.
    PubMed     Text format     Abstract available


    Mol Psychiatry

  7. ROALF DR, de la Garza AG, Rosen A, Calkins ME, et al
    Alterations in white matter microstructure in individuals at persistent risk for psychosis.
    Mol Psychiatry. 2019 Feb 5. pii: 10.1038/s41380-019-0360.
    PubMed     Text format     Abstract available


    Neuropsychopharmacology

  8. KESHAVAN MS
    Larry J Seidman.
    Neuropsychopharmacology. 2018;43:1189-1190.
    PubMed     Text format    


    Pharmacopsychiatry

  9. ZHENG W, Zhang QE, Cai DB, Yang XH, et al
    Combination of Metformin and Lifestyle Intervention for Antipsychotic-Related Weight Gain: A Meta-Analysis of Randomized Controlled Trials.
    Pharmacopsychiatry. 2019;52:24-31.
    PubMed     Text format     Abstract available


    PLoS One

  10. SEVILLA G, Rossello J, Salvador R, Sarro S, et al
    Deficits in nominal reference identify thought disordered speech in a narrative production task.
    PLoS One. 2018;13:e0201545.
    PubMed     Text format     Abstract available


    Psychiatry Res

  11. DORE-GAUTHIER V, Cote H, Jutras-Aswad D, Ouellet-Plamondon C, et al
    How to help homeless youth suffering from first episode psychosis and substance use disorders? The creation of a new intensive outreach intervention team.
    Psychiatry Res. 2019;273:603-612.
    PubMed     Text format     Abstract available

  12. PALMA C, Farriols N, Frias A, Canete J, et al
    Randomized controlled trial of cognitive-motivational therapy program (PIPE) for the initial phase of schizophrenia: Maintenance of efficacy at 5-year follow up().
    Psychiatry Res. 2019;273:586-594.
    PubMed     Text format     Abstract available

  13. CALIGIURI MP, Teulings HL, Dean CE, Lohr JB, et al
    The nature of bradykinesia in schizophrenia treated with antipsychotics.
    Psychiatry Res. 2019;273:537-543.
    PubMed     Text format     Abstract available

  14. YANG Y, Liu Y, Wang G, Hei G, et al
    Brain-derived neurotrophic factor is associated with cognitive impairments in first-episode and chronic schizophrenia.
    Psychiatry Res. 2019;273:528-536.
    PubMed     Text format     Abstract available

  15. NGO DYJ, Thomson WM, Subramaniam M, Abdin E, et al
    The oral health of long-term psychiatric inpatients in Singapore.
    Psychiatry Res. 2018;266:206-211.
    PubMed     Text format     Abstract available

  16. CHENG Z, Yuan Y, Han X, Yang L, et al
    Rates and predictors of one-year antipsychotic treatment discontinuation in first-episode schizophrenia: Results from an open-label, randomized, "real world" clinical trial.
    Psychiatry Res. 2019;273:631-640.
    PubMed     Text format     Abstract available


    Psychol Med

  17. JAASKELAINEN E, Juola T, Korpela H, Lehtiniemi H, et al
    Epidemiology of psychotic depression - systematic review and meta-analysis.
    Psychol Med. 2018;48:905-918.
    PubMed     Text format     Abstract available

  18. SELTEN JP, van der Ven E, Termorshuizen F
    Migration and psychosis: a meta-analysis of incidence studies.
    Psychol Med. 2019 Feb 6:1-11. doi: 10.1017/S0033291719000035.
    PubMed     Text format     Abstract available


    Schizophr Res

  19. FRIEDMAN-YAKOOBIAN M, Parrish EM, Thomas A, Lesser R, et al
    An integrated neurocognitive and social-cognitive treatment for youth at clinical high risk for psychosis: Cognition for Learning and for Understanding Everyday Social Situations (CLUES).
    Schizophr Res. 2019 Feb 4. pii: S0920-9964(19)30033.
    PubMed     Text format     Abstract available

  20. QUEDNOW BB, Ejebe K, Wagner M, Giakoumaki SG, et al
    Meta-analysis on the association between genetic polymorphisms and prepulse inhibition of the acoustic startle response.
    Schizophr Res. 2018;198:52-59.
    PubMed     Text format     Abstract available

  21. WAGNER E, Wobrock T, Kunze B, Langguth B, et al
    Efficacy of high-frequency repetitive transcranial magnetic stimulation in schizophrenia patients with treatment-resistant negative symptoms treated with clozapine.
    Schizophr Res. 2019 Jan 28. pii: S0920-9964(19)30029.
    PubMed     Text format     Abstract available

  22. CAO H, Chung Y, McEwen SC, Bearden CE, et al
    Progressive reconfiguration of resting-state brain networks as psychosis develops: Preliminary results from the North American Prodrome Longitudinal Study (NAPLS) consortium.
    Schizophr Res. 2019 Jan 28. pii: S0920-9964(19)30024.
    PubMed     Text format     Abstract available

  23. GOFF DC, Freudenreich O, Cather C, Holt D, et al
    Citalopram in first episode schizophrenia: The DECIFER trial.
    Schizophr Res. 2019 Jan 29. pii: S0920-9964(19)30018.
    PubMed     Text format     Abstract available

  24. GOMES FV, Zhu X, Grace AA
    Stress during critical periods of development and risk for schizophrenia.
    Schizophr Res. 2019 Jan 30. pii: S0920-9964(19)30020.
    PubMed     Text format     Abstract available

  25. XU P, Klaasen NG, Opmeer EM, Pijnenborg GHM, et al
    Intrinsic mesocorticolimbic connectivity is negatively associated with social amotivation in people with schizophrenia.
    Schizophr Res. 2019 Jan 31. pii: S0920-9964(19)30031.
    PubMed     Text format     Abstract available

  26. HANLON FM, Yeo RA, Shaff NA, Wertz CJ, et al
    A symptom-based continuum of psychosis explains cognitive and real-world functional deficits better than traditional diagnoses.
    Schizophr Res. 2019 Jan 30. pii: S0920-9964(19)30027.
    PubMed     Text format     Abstract available

  27. BRADLEY ER, van Nieuwenhuizen A, Abram S, Niles AN, et al
    Oxytocin does not improve working memory in schizophrenia.
    Schizophr Res. 2019 Jan 31. pii: S0920-9964(19)30017.
    PubMed     Text format    

  28. YANG YS, Davis MC, Wynn JK, Hellemann G, et al
    N-acetylcysteine improves EEG measures of auditory deviance detection and neural synchronization in schizophrenia: A randomized, controlled pilot study.
    Schizophr Res. 2019 Jan 31. pii: S0920-9964(19)30039.
    PubMed     Text format    

  29. SHI C, Kang L, Yao S, Ma Y, et al
    What is the optimal neuropsychological test battery for schizophrenia in China?
    Schizophr Res. 2019 Feb 1. pii: S0920-9964(19)30037.
    PubMed     Text format     Abstract available

  30. RODRIGUES R, MacDougall AG, Zou G, Lebenbaum M, et al
    Involuntary hospitalization among young people with early psychosis: A population-based study using health administrative data.
    Schizophr Res. 2019 Feb 4. pii: S0920-9964(19)30046.
    PubMed     Text format     Abstract available

  31. BIAGIANTI B, Fisher M, Brandrett B, Schlosser D, et al
    Development and testing of a web-based battery to remotely assess cognitive health in individuals with schizophrenia.
    Schizophr Res. 2019 Feb 4. pii: S0920-9964(19)30036.
    PubMed     Text format     Abstract available

  32. SANTILLO AF, Lundgren S, Xu C, Orhan F, et al
    Neurogranin as a potential synaptic marker in the cerebrospinal fluid of patients with a first episode psychosis.
    Schizophr Res. 2019 Feb 4. pii: S0920-9964(19)30010.
    PubMed     Text format    

  33. PALANIYAPPAN L, Das TK, Winmill L, Hough M, et al
    Progressive post-onset reorganisation of MRI-derived cortical thickness in adolescents with schizophrenia.
    Schizophr Res. 2019 Feb 2. pii: S0920-9964(19)30044.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: